Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xinnaoning
- Development stage
- Phase 4
- Lead developer
- Guizhou Jingcheng Pharmaceutical
- Modality
- Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Xinnaoning is a Traditional Chinese Medicine (TCM) formulation, primarily available as a capsule, used for the treatment of cardiovascular and cerebrovascular diseases. It is specifically indicated for chronic stable angina pectoris associated with "Qi stagnation and blood stasis syndrome" in TCM theory. The formulation is a complex mixture of botanical extracts, including *Ginkgo biloba*, *Salvia miltiorrhiza*, *Panax notoginseng*, and *Pueraria lobata*, which work synergistically to promote blood circulation, resolve blood stasis, and improve blood flow to the heart and brain. It is developed and manufactured by Guizhou Bailing Group Pharmaceutical and has been evaluated in Phase 4 clinical trials to confirm its efficacy and safety in patients with stable angina.
- Brand names
- XinnaoningXinnaoning Capsule
- Other names
- Xinnaoning Jiaonang
Beyond the preview
Go deeper on Xinnaoning.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xinnaoning.